Ruxolitinib

Ruxolitinib ATC Code L01XE18 : Antineoplastic and immunomodulating agents - Antineoplastic drugs - Other antineoplastic agents - Protein kinase inhibitors - Ruxolitinib
Ruxolitinib
Ruxolitinib
LatinRuxolitinibum
Routes..Oral, topical
Pregnancy categoryC
FDA Approval Date2011-11-16
EMA Approval Date2012-08-23
Molecular Weight306.36502 g/mol
Molecular FormulaC17H18N6
CAS Number941678-49-5
Ruxolitinib 3D

Ruxolitinib list of brand/trade names

  • United States: Jakafi
  • United Kingdom: Jakavi
  • Germany: Jakavi
  • Spain: Jakavi
  • Canada: Jakavi
  • Denmark: Jakavi
  • Finland: Jakavi
  • Norway: Jakavi
  • Sweden: Jakavi
  • Switzerland: Jakavi
  • Turkey: Jakavi


ATC Codes

  1. Alimentary tract and metabolisma
  2. Blood and blood forming organs
  3. Cardiovascular system
  4. Dermatological drugs
  5. Genitourinary system and reproductive hormones
  6. Systemic hormonal preparations, excluding reproductive hormones and insulins
  7. Antiinfectives for systemic use
  8. Antineoplastic and immunomodulating agents
  9. Musculoskeletal system
  10. Nervous system
  11. Antiparasitic products, insecticides and repellents
  12. Respiratory system
  13. Sensory organs
  14. Various ATC structures

The newly added categories

  1. Mecillinam
  2. Tofisopam
  3. Medazepam
  4. Chlordiazepoxide
  5. Diazepam
  6. Bacampicillin
  7. Pivmecillinam
  8. Tigecycline
  9. Amoxicillin
  10. Mezlocillin